Elevated methemoglobin levels in patients treated with hydroxocobalamin: a case series and in-vitro analysis
- 12 May 2022
- journal article
- research article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 60 (9) , 1012-1018
Abstract
Historically, the first step in treating cyanide (CN-) toxicity utilized antidotes to induce methemoglobinemia. This is concerning in patients who are already hypoxemic or have elevated carboxyhemo...Keywords
Funding Information
- Pfizer Investigator Initiated Research Grant
This publication has 28 references indexed in Scilit:
- Prevalence of hydrogen cyanide and carboxyhaemoglobin in victims of smoke inhalation during enclosed-space fires: a combined toxicological riskClinical Toxicology, 2012
- Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurementsClinica Chimica Acta, 2009
- Spectrophotometry of hydroxocobalamin and hemoglobin reveals production of an unanticipated methemoglobin variantClinical Toxicology, 2008
- Potential Interference by Hydroxocobalamin on Cooximetry Hemoglobin Measurements During Cyanide and Smoke Inhalation TreatmentsAnnals of Emergency Medicine, 2007
- Hydroxocobalamin as a Cyanide AntidoteAmerican Journal of Therapeutics, 2006
- Case 23-2004New England Journal of Medicine, 2004
- Value of lactic acidosis in the assessment of the severity of acute cyanide poisoningCritical Care Medicine, 2002
- Toxicity of Fire SmokeCritical Reviews in Toxicology, 2002
- Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kitAnnals of Emergency Medicine, 1993
- Kinetics of amyl nitrite-induced hemoglobin oxidation in cord and adult bloodToxicology, 1985